FAP and neoplasm: We investigated whether CAFs could be eliminated in tumor sites by FAP-targeted CAR-T cells and further improve the antitumor ability of CLDN18.2-targeted CAR-T cells by TME remodeling, aiming to develop an effective and safe pancreatic cancer treatment strategy.